Notes And Other Explanatory Information [Abstract]

Captor Therapeutics S.A. - Filing #6179999

Concept	2022-01-01 to 2022-12-31
Notes and other explanatory information [abstract]
Disclosure of accounting judgements and estimates [text block]	14
Disclosure of auditors' remuneration [text block]	46.       Wynagrodzenie firmy audytorskiej
Disclosure of authorisation of financial statements [text block]	4
Disclosure of basis of consolidation [text block]	7
Disclosure of basis of preparation of financial statements [text block]	5
Disclosure of borrowings [text block]	36
Disclosure of business combinations [text block]	28
Disclosure of cash and cash equivalents [text block]	33. Środki pieniężne i ich ekwiwalenty
Disclosure of cash flow statement [text block]	43
Disclosure of changes in accounting policies [text block]	12
Disclosure of changes in accounting policies, accounting estimates and errors [text block]	10
Disclosure of collateral [text block]
Disclosure of commitments and contingent liabilities [text block]	40
Disclosure of credit risk [text block]	47.4    Ryzyko kredytowe
Disclosure of deferred income [text block]	39
Disclosure of deferred taxes [text block]	20
Disclosure of discontinued operations [text block]	21
Disclosure of dividends [text block]	24
Disclosure of earnings per share [text block]	22
Disclosure of employee benefits [text block]	17
Disclosure of entity's operating segments [text block]	15
Disclosure of events after reporting period [text block]	53.       Zdarzenia następujące po dniu bilansowym
Disclosure of expenses [text block]	17
Disclosure of expenses by nature [text block]	17
Disclosure of fair value of financial instruments [text block]	48.       Instrumenty finansowe
Disclosure of finance income (cost) [text block]	19
Disclosure of financial risk management [text block]
Disclosure of general information about financial statements [text block]	INFORMACJE OGÓLNE
Disclosure of going concern [text block]	13
Disclosure of impairment of assets [text block]	17
Disclosure of income tax [text block]
Disclosure of information about employees [text block]	51. Struktura zatrudnienia
Disclosure of information about key management personnel [text block]	45
Disclosure of intangible assets [text block]	27
Disclosure of issued capital [text block]
Disclosure of leases [text block]	37
Disclosure of liquidity risk [text block]
Disclosure of market risk [text block]	47.1      Ryzyko stopy procentowej
Disclosure of non-current assets or disposal groups classified as held for sale [text block]	Grupa klasyfikuje składnik aktywów trwałych (lub grupę) jako przeznaczony do sprzedaży, jeśli jego wartość bilansowa zostanie odzyskana przede wszystkim w drodze transakcji sprzedaży, a nie poprzez jego dalsze wykorzystanie.
Disclosure of objectives, policies and processes for managing capital [text block]
Disclosure of other current assets [text block]	31. Inne aktywa finansowe
Disclosure of other non-current assets [text block]	29
Disclosure of other operating expense [text block]	18
Disclosure of property, plant and equipment [text block]	26
Disclosure of provisions [text block]	35
Disclosure of related party [text block]	44
Disclosure of research and development expense [text block]	25
Disclosure of reserves within equity [text block]	34
Disclosure of restricted cash and cash equivalents [text block]	Grupa nie posiada środków pieniężnych o ograniczonej możliwości dysponowania.
Disclosure of revenue [text block]	16
Disclosure of share capital, reserves and other equity interest [text block]	34
Disclosure of share-based payment arrangements [text block]	34
Disclosure of subsidiaries [text block]	2
Disclosure of tax receivables and payables [text block]	42
Disclosure of trade and other payables [text block]	38
Disclosure of trade and other receivables [text block]	30
Disclosure of treasury shares [text block]	34.1.1  Wartość nominalna akcji